NCT02201849 A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults Status COMPLETED Phase PHASE1
NCT02201108 Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT02200718 A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis Status UNKNOWN Phase PHASE1
NCT02184494 Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT02170779 Developing and Testing a Comprehensive MS Spasticity Management Program Status COMPLETED Phase PHASE2
NCT02152085 Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis Status COMPLETED Phase NA
NCT02149706 A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis Status UNKNOWN Phase PHASE2
NCT02146534 Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients Status COMPLETED Phase PHASE4
NCT02143167 Resistance Training and Amino Pyridine in Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT02142764 Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT02141386 Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis Status UNKNOWN Phase NA
NCT02141022 Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya Status COMPLETED Phase NA
NCT02139696 Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation Status COMPLETED Phase N/A
NCT02137109 Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri Status COMPLETED Phase N/A
NCT02137044 Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study Status COMPLETED Phase NA
NCT02133664 Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2